CA3223875A1 - Heterocycloalkyl-substituted polyheteroazole derivatives as medicaments for treating and/or preventing rs virus infections - Google Patents
Heterocycloalkyl-substituted polyheteroazole derivatives as medicaments for treating and/or preventing rs virus infections Download PDFInfo
- Publication number
- CA3223875A1 CA3223875A1 CA3223875A CA3223875A CA3223875A1 CA 3223875 A1 CA3223875 A1 CA 3223875A1 CA 3223875 A CA3223875 A CA 3223875A CA 3223875 A CA3223875 A CA 3223875A CA 3223875 A1 CA3223875 A1 CA 3223875A1
- Authority
- CA
- Canada
- Prior art keywords
- optionally substituted
- chem
- aryl
- alkyl
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021106034 | 2021-06-25 | ||
| JP2021-106034 | 2021-06-25 | ||
| PCT/JP2022/025361 WO2022270628A1 (ja) | 2021-06-25 | 2022-06-24 | Ｒｓウイルス感染症の処置および／または予防用医薬としてのヘテロシクロアルキル置換ポリヘテロアゾール誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3223875A1 true CA3223875A1 (en) | 2022-12-29 |
Family
ID=84545504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3223875A Pending CA3223875A1 (en) | 2021-06-25 | 2022-06-24 | Heterocycloalkyl-substituted polyheteroazole derivatives as medicaments for treating and/or preventing rs virus infections |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240327392A1 (https=) |
| EP (1) | EP4361148A4 (https=) |
| JP (1) | JPWO2022270628A1 (https=) |
| CN (1) | CN117730079A (https=) |
| AU (1) | AU2022296214A1 (https=) |
| CA (1) | CA3223875A1 (https=) |
| WO (1) | WO2022270628A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025206404A1 (ja) * | 2024-03-29 | 2025-10-02 | 国立大学法人 大分大学 | 線維症治療のための抗線維化化合物 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL140040A0 (en) * | 1998-06-03 | 2002-02-10 | Guilford Pharm Inc | N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| DOP2000000107A (es) * | 1999-12-01 | 2002-09-16 | Agouron Pharmaceutical Inc | Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas |
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| JP4221989B2 (ja) * | 2002-09-30 | 2009-02-12 | 大正製薬株式会社 | オキサジアゾール誘導体 |
| JP4240978B2 (ja) * | 2002-09-30 | 2009-03-18 | 大正製薬株式会社 | アリールオキシメチルオキサジアゾール誘導体 |
| JP2006523669A (ja) * | 2003-03-10 | 2006-10-19 | ファイザー・インク | Ｎｉｍａ調節タンパク質（ｐｉｎ１）を阻害するための、リン酸／硫酸エステル化合物および医薬組成物 |
| EP1604989A1 (en) * | 2004-06-08 | 2005-12-14 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | DPP-IV inhibitors |
| EP1981845A2 (en) * | 2006-02-08 | 2008-10-22 | Wyeth | Sulfonamide derivatives to treat infection with hepatitis c virus |
| MX2012007420A (es) * | 2009-12-24 | 2012-07-23 | Vertex Pharma | Analogos para el tratamiento o prevencion de infecciones de flavivirus. |
| CN102869657A (zh) * | 2010-03-24 | 2013-01-09 | 沃泰克斯药物股份有限公司 | 用于治疗或预防黄病毒感染的类似物 |
| JP6122868B2 (ja) * | 2011-12-22 | 2017-04-26 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン |
| JP2016504284A (ja) * | 2012-11-16 | 2016-02-12 | バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 抗ウイルス性アザ糖を含有するヌクレオシド |
| US9637516B2 (en) * | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
| US20170129916A1 (en) * | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| WO2015198263A2 (en) * | 2014-06-26 | 2015-12-30 | Hetero Research Foundation | Novel betulinic proline substituted derivatives as hiv inhibitors |
| WO2016091774A1 (en) * | 2014-12-08 | 2016-06-16 | Janssen Sciences Ireland Uc | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) |
| WO2018051254A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators |
| WO2018051255A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators |
| JP6862305B2 (ja) | 2017-07-13 | 2021-04-21 | 株式会社マキタ | 衣服及び報知システム |
| RU2712097C1 (ru) * | 2018-09-28 | 2020-01-24 | Общество с ограниченной ответственностью "Необиотек" | Ингибитор дипептидилпептидазы-4 для лечения сахарного диабета 2-го типа, соединения (варианты) |
| JP7684282B2 (ja) * | 2020-03-31 | 2025-05-27 | 田辺三菱製薬株式会社 | ヒドロキシピロリジン誘導体およびその医薬用途 |
-
2022
- 2022-06-24 US US18/573,760 patent/US20240327392A1/en active Pending
- 2022-06-24 CA CA3223875A patent/CA3223875A1/en active Pending
- 2022-06-24 EP EP22828544.1A patent/EP4361148A4/en active Pending
- 2022-06-24 CN CN202280044481.9A patent/CN117730079A/zh active Pending
- 2022-06-24 AU AU2022296214A patent/AU2022296214A1/en active Pending
- 2022-06-24 JP JP2023530145A patent/JPWO2022270628A1/ja active Pending
- 2022-06-24 WO PCT/JP2022/025361 patent/WO2022270628A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4361148A1 (en) | 2024-05-01 |
| EP4361148A4 (en) | 2025-07-09 |
| JPWO2022270628A1 (https=) | 2022-12-29 |
| AU2022296214A1 (en) | 2024-01-25 |
| WO2022270628A1 (ja) | 2022-12-29 |
| US20240327392A1 (en) | 2024-10-03 |
| CN117730079A (zh) | 2024-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020213376B2 (en) | Compounds and methods for the targeted degradation of the androgen receptor | |
| AU2022271425B2 (en) | Processes of making and crystalline forms of a MDM2 inhibitor | |
| AU2022201929B2 (en) | Inhibitors of (alpha-v)(beta-6) integrin | |
| US11639353B2 (en) | Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors | |
| CN106255679B (zh) | 用作nav通道抑制剂的杂环化合物及其用途 | |
| CN110573499B (zh) | αvβ6整合蛋白的抑制剂 | |
| KR20210006356A (ko) | 단백질분해 조절제 및 연관된 사용 방법 | |
| CA3072926A1 (en) | Spirocycle compounds and methods of making and using same | |
| EP3656782A1 (en) | Peptide amide compound and preparation method and medical use thereof | |
| JP7564528B2 (ja) | 狂犬病の治療のための化合物およびその方法 | |
| CN116635378A (zh) | 二环1,4-二氮杂环庚酮和其治疗用途 | |
| JP2023549187A (ja) | 貧血およびがんの処置のためのｖｈｌ阻害剤としての１－（２－（４－シクロプロピル－１ｈ－１，２，３－トリアゾール－１－イル）アセチル）－４－ヒドロキシ－ｎ－（ベンジル）ピロリジンｅ－２－カルボキサミド誘導体 | |
| CN111606970B (zh) | 一种1，5-二氮杂双环[5,3,0]十烷酮氨基酸衍生物及其制备方法和应用 | |
| CA3223875A1 (en) | Heterocycloalkyl-substituted polyheteroazole derivatives as medicaments for treating and/or preventing rs virus infections | |
| FR2928150A1 (fr) | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens | |
| JPH04128291A (ja) | 新規なヘテロ環化合物およびその製造法 | |
| HK40037289A (en) | Inhibitors of (alpha-v)(beta-6) integrin | |
| HK1231864A1 (en) | Heterocyclic compounds as nav channel inhibitors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251224 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20260224 |